Illumina (ILMN) confirmed the election of David King to its Board of Directors, effective immediately following the company’s annual meeting of shareholders. King’s election marks an important addition to Illumina’s Board as the company accelerates its clinical strategy to integrate genomics more broadly into the standard of care. . King is the former Executive Chairman and Chief Executive Officer of Labcorp (LH).
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN: